LOGIN  |  REGISTER
Amneal Pharmaceuticals
Assertio

DocGo Releases Annual ESG Report, Outlining Commitment to Ethical Mobile Healthcare Initiatives

December 06, 2022 | Last Trade: US$1.50 0.06 -3.85
  • The report highlights the company’s corporate responsibility programs, including serving diverse communities and at-risk populations, as well as carbon and waste reduction efforts

EW YORK--(BUSINESS WIRE)--DocGo (Nasdaq: DCGO), a leading provider of last-mile mobile health services, today announced the release of its annual Social Impact and Sustainability Report. The report provides an overview of the progress DocGo has made across a range of Environmental, Social, and Governance (ESG) programs.

“DocGo was founded with a mission to serve the public and improve the overall quality of healthcare like no other company has before,” said Stephen Sugrue, DocGo’s Chief Compliance Officer. “We have acted diligently beyond our innovative care model as we build on our fundamentals and take a significant step forward in our sustainability journey of creating a better way of life. I am immensely proud of our ambition and leadership to deliver better results for our people, communities and environment.”

The report highlights DocGo’s efforts promoting social impact, expanded diversification, equity and sustainable climate action, which include:

  • Preventing more than 7,600 emergency department visits and hospitalizations for at-risk communities through its mobile health services.
  • Expanding access to health care for sheltered and unsheltered homeless and asylees in NYC.
  • Providing healthcare treatment across over 6,000,000 cumulative patient encounters.
  • Expanding its diversity recruitment efforts to improve on the company’s 60% Team Blue diversity makeup.
  • Diverting more than 15.6 million pounds of CO2 through its fuel-efficient vehicle fleet.
  • Unveiling the nation’s first all-electric ambulance and announcing a targeted full conversion of its fleet to all-electric by 2032.

More information on the company’s sustainability progress can be found in the full report: www.docgo.com/social-impact-sustainability/

About DocGo

DocGo is a leading provider of last-mile mobile care services. DocGo is disrupting the traditional four-wall healthcare system by providing high quality, highly affordable care to patients where and when they need it. DocGo's innovative technology and dedicated field staff of certified health professionals elevate the quality of patient care and drive business efficiencies for facilities, hospital networks, and health insurance providers. With Mobile Health, DocGo empowers the full promise and potential of telehealth by facilitating healthcare treatment, in tandem with a remote physician, in the comfort of a patient's home or workplace. Together with DocGo's integrated Ambulnz medical transport services, DocGo is bridging the gap between physical and virtual care. For more information, please visit www.docgo.com.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “may,” “will,” “should,” “likely,” “anticipates,” “expects,” “intends,” “plans,” “projects,” “believes,” “estimates,” “outlook” and similar expressions are used to identify these forward-looking statements. These statements are based on current expectations and beliefs and are subject to uncertainty and changes in circumstances. Actual results may vary materially from those expressed or implied by the statements in this press release due to the risks, uncertainties and other factors described in the Company’s filings with the Securities and Exchange Commission. More detailed information about factors that could affect future results is contained in our filings with the Securities and Exchange Commission. The “forward-looking statements” included in this press release are made only as of the date of this release. We do not have and do not undertake any obligation to publicly update any “forward-looking statements” to reflect subsequent events or circumstances, and we expressly disclaim any such obligation, except as required by law or regulation.

 

Recursion

Stock Quote

Featured Stock

Amneal Pharmaceuticals

Amneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...

CLICK TO LEARN MORE

Featured Stock

Terns Pharmaceuticals

Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page